Literature DB >> 9881705

Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers.

P Abujiang1, T J Mori, T Takahashi, F Tanaka, I Kasyu, S Hitomi, H Hiai.   

Abstract

Our recent linkage study of urethane-induced pulmonary adenomas in SMXA RI strains of mouse revealed two host resistance genes, Par1 (chromosome 11) and Par3 (chromosome 12). The map positions of Par1 and Par3 correspond to human 17q11-23 and 14q11-24, based on synteny between mouse and human. In this study, we examined the loss of heterozygosity (LOH) in these two homologous human chromosomal regions in 30 primary lung adenocarcinoma samples with matched normal DNA. Using 15 highly polymorphic markers, two commonly deleted regions were identified on human chromosomes 14 and 17, respectively. At 17q21, nine (53%) of 17 informative tumors showed LOH between D17S588 and D17S518. On the other hand, at 14q11-12, seven (32%) of 22 informative tumors showed LOH at loci between D14S261 and D14S80. Subsequently, we examined 25 squamous cell carcinomas (SQ) and 24 small cell carcinomas (SCC). At 14q11-12, six (38%) of 16 informative SQ and five (42%) of 12 informative SCC showed LOH. In contrast, at 17q11-23, one (7%) of 15 informative SQ and two (14%) of 14 SCC showed LOH. Therefore, the gene on 17q seemed to affect selectively adenocarcinomas, whereas the other gene on 14q, all three types of lung carcinomas. These observations indicate that a comparative genetic analysis provides a promising approach to survey genes involved in multifactorial process of human lung carcinogenesis.

Entities:  

Mesh:

Year:  1998        PMID: 9881705     DOI: 10.1038/sj.onc.1202230

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Microarray analysis of promoter methylation in lung cancers.

Authors:  Masayuki Fukasawa; Mika Kimura; Sumiyo Morita; Kenichi Matsubara; Sumitaka Yamanaka; Chiaki Endo; Akira Sakurada; Masami Sato; Takashi Kondo; Akira Horii; Hiroyuki Sasaki; Izuho Hatada
Journal:  J Hum Genet       Date:  2006-01-25       Impact factor: 3.172

2.  MicroRNAs as molecular classifiers for cancer.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Cell Cycle       Date:  2011-09-01       Impact factor: 4.534

3.  STRAD in Peutz-Jeghers syndrome and sporadic cancers.

Authors:  W W J de Leng; J J Keller; S Luiten; A R Musler; M Jansen; A F Baas; F W M de Rooij; J J P Gille; F H Menko; G J A Offerhaus; M A J Weterman
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  Mapping tumor-suppressor genes with multipoint statistics from copy-number-variation data.

Authors:  Iuliana Ionita; Raoul-Sam Daruwala; Bud Mishra
Journal:  Am J Hum Genet       Date:  2006-05-30       Impact factor: 11.025

5.  Genome-wide prediction of imprinted murine genes.

Authors:  Philippe P Luedi; Alexander J Hartemink; Randy L Jirtle
Journal:  Genome Res       Date:  2005-06       Impact factor: 9.043

6.  Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.

Authors:  Alain C Borczuk; Jianming Pei; Robert N Taub; Brynn Levy; Odelia Nahum; Jinli Chen; Katherine Chen; Joseph R Testa
Journal:  Cancer Biol Ther       Date:  2016-02-06       Impact factor: 4.742

7.  Both gene amplification and allelic loss occur at 14q13.3 in lung cancer.

Authors:  Thomas Harris; Qiulu Pan; Juan Sironi; Dionne Lutz; Jianmin Tian; Jana Sapkar; Roman Perez-Soler; Steven Keller; Joseph Locker
Journal:  Clin Cancer Res       Date:  2010-12-10       Impact factor: 12.531

Review 8.  Binding of pro-prion to filamin A: by design or an unfortunate blunder.

Authors:  C Li; W Xin; M-S Sy
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

Review 9.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

10.  Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.

Authors:  I Ferrer; E M Verdugo-Sivianes; M A Castilla; R Melendez; J J Marin; S Muñoz-Galvan; J L Lopez-Guerra; B Vieites; M J Ortiz-Gordillo; J M De León; J M Praena-Fernandez; M Perez; J Palacios; A Carnero
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.